PLASMAB Trademark

Trademark Overview

On Tuesday, December 17, 2019, a trademark application was filed for PLASMAB with the United States Patent and Trademark Office. The USPTO has given the PLASMAB trademark a serial number of 88729897. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 16, 2023. This trademark is owned by GeneOne Life Science. The PLASMAB trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for the treatment of infectious diseases, inflammatory disease, and cancer
plasmab

General Information

Serial Number88729897
Word MarkPLASMAB
Filing DateTuesday, December 17, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 16, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2020

Trademark Statements

Goods and ServicesBiological preparations for the treatment of infectious diseases, inflammatory disease, and cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 20, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGeneOne Life Science
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSeoul 06060
KR
Party NameGeneOne Life Science
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSeoul 06060
KR

Trademark Events

Event DateEvent Description
Tuesday, January 17, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 16, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, June 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 9, 2022SOU EXTENSION 4 GRANTED
Thursday, June 9, 2022SOU EXTENSION 4 FILED
Thursday, June 9, 2022TEAS EXTENSION RECEIVED
Friday, December 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 8, 2021SOU EXTENSION 3 GRANTED
Wednesday, December 8, 2021SOU EXTENSION 3 FILED
Wednesday, December 8, 2021TEAS EXTENSION RECEIVED
Thursday, June 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 8, 2021SOU EXTENSION 2 GRANTED
Tuesday, June 8, 2021SOU EXTENSION 2 FILED
Tuesday, June 8, 2021TEAS EXTENSION RECEIVED
Tuesday, December 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, December 6, 2020SOU EXTENSION 1 GRANTED
Sunday, December 6, 2020SOU EXTENSION 1 FILED
Sunday, December 6, 2020TEAS EXTENSION RECEIVED
Tuesday, June 16, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 19, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 16, 2020ASSIGNED TO EXAMINER
Friday, December 20, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 20, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

plasmab inflammatory disease cancer diseases infectious preparations treatment biological